For years, the only way to take Wegovy was with a weekly injection. That changed in January 2026 when the FDA approved oral Wegovy — a once-daily semaglutide pill — making it the first oral GLP-1 medication approved specifically for weight loss. If you’re considering a GLP-1 medication, the question is no longer if you should try one, but which form fits your life.
The Efficacy Comparison
Both forms of Wegovy use the same active ingredient — semaglutide — but at different doses and delivery methods. The injectable version (2.4mg weekly) produced approximately 15% mean body weight loss in the landmark STEP 1 trial. The oral pill (25mg daily) showed 16.6% mean weight loss at 64 weeks in the OASIS 4 trial, with one in three participants losing 20% or more of their body weight.
Key finding: Oral Wegovy’s 16.6% weight loss at 64 weeks is comparable to — and slightly exceeds — the injectable version’s ~15% in clinical trials.
The takeaway? The pill performs at least as well as the injection, which is remarkable for an oral formulation. If you’re weighing semaglutide against tirzepatide, the oral option adds yet another dimension to the decision.
How You Take Each One
This is where the practical differences matter most. The injectable Wegovy is a once-weekly subcutaneous injection, typically in the thigh, abdomen, or upper arm. Most patients learn to self-inject in minutes, and the prefilled pen makes it straightforward.
The oral pill requires a stricter daily routine. You must take it first thing in the morning on an empty stomach with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking other medications. This isn’t optional — food and excess liquid significantly reduce absorption. For people who already take morning medications or who grab breakfast immediately, this adjustment takes planning.
Cost Comparison
Novo Nordisk launched the oral Wegovy starting dose at $149 per month for self-pay patients, making it the most affordable branded GLP-1 option to date. The injectable version costs $349-$499 per month self-pay depending on dose. If you’re navigating GLP-1 costs in 2026, the pill is a meaningfully cheaper entry point.
| Feature | Oral Wegovy | Injectable Wegovy |
|---|---|---|
| Dosing | Once daily (25mg pill) | Once weekly (2.4mg injection) |
| Weight loss (trials) | ~16.6% (OASIS 4) | ~15% (STEP 1) |
| Self-pay cost | From $149/mo | $349–$499/mo |
| Refrigeration | Not required | Required before first use |
| Food restrictions | Empty stomach, 30-min wait | None |
| Needle required | No | Yes |
Storage and Convenience
One underrated advantage of the pill: no refrigeration. Injectable Wegovy must be refrigerated before its first use (it can stay at room temperature for up to 28 days after). The pill stores at room temperature indefinitely. For people who travel frequently, this is a real quality-of-life win.
Side Effects
Both forms share the same core side effects because the mechanism is identical — nausea, constipation, diarrhea, and vomiting, particularly during the dose-titration period. If you’re starting either form, our guide to your first month on a GLP-1 covers what to expect and how to manage symptoms. The oral version may cause slightly more GI effects because the drug is absorbed through the stomach lining.
Who Should Choose the Pill vs the Injection?
The pill is likely a better fit if you have a needle aversion, want the lower cost entry point, travel frequently and need room-temperature storage, or prefer a daily habit over a weekly one. The injection may be better if you struggle with morning routines (no food restrictions), take other medications first thing in the morning, want the once-weekly simplicity, or have GI conditions that might affect oral absorption.
Ready to explore GLP-1 options? Compare telehealth providers offering both oral and injectable semaglutide — with licensed physicians and home delivery.
Compare Providers →What About Orforglipron?
It’s worth noting that Eli Lilly’s orforglipron is expected to receive FDA approval in spring 2026. Unlike oral Wegovy, orforglipron has no food or water restrictions at all — making it potentially even more convenient. If convenience is your primary concern, this pipeline drug is worth watching.
The Bottom Line
Oral Wegovy is a genuine breakthrough — the first time patients have had a clinically proven GLP-1 pill for weight management. Its efficacy matches the injection, the cost is lower, and for many people, a daily pill beats a weekly needle. The tradeoff is a strict morning routine and potentially more GI sensitivity. Either way, having both options means more people can find a form that fits their life — and that’s the real win.